Business
Cadila Healthcare gets USFDA nod for metronidazole tablets
Chennai, Nov 21: Pharma major Cadila Healthcare Ltd. on Monday said it has received the final approval from the US Food and Drug Administration (USFDA) to market metronidazole tablets.
In a regulatory filing with BSE, Cadila Healthcare said it has got USFDA's approval to market metronidazole in strengths 250 mg and 500 mg tablets.
The drug is used to treat infections caused by bacteria or parasites.
According to Cadila Healthcare, the tablets will be made at the group's formulations manufacturing facility at Baddi in Himachal Pradesh.
The company said the group now has more than 105 approvals and has so far filed nearly 275 ANDAs (Abbreviated New Drug Application) since the commencement of the filing process in FY 2003-04.
4 hours ago
Karnataka bypolls: Nikhil Kumaraswamy named NDA candidate from Channapatna Assembly seat
4 hours ago
Congress not to field candidates in UP Assembly bypolls, announces support for Samajwadi Party
4 hours ago
FM Sitharaman, World Bank President discuss issues related to private capital participation in Global Public Goods
4 hours ago
Large turnout for early voters in US swing state Georgia; focus on economy, people's rights
4 hours ago
19-Year-Old Sikh Woman Tragically Dies While Working at Walmart in Halifax, Canada
5 hours ago
OpenAI Names Indian-American Economist Dr. Aaron Chatterji as Its First Chief Economist
5 hours ago
We have long recognised and experienced Khalistani extremism, says Canadian MP Chandra Arya
5 hours ago
Canada: Dissident MPs call for Trudeau's resignation, deadline set for October 28
5 hours ago
US-India partnership vital for preserving peace in Indo-Pacific region: Former White House official Lisa Curtis
6 hours ago
Threats to U.S. Democracy: A Viewpoint
6 hours ago
Justice Siddaiah Rachaiah appointed permanent judge in Karnataka HC
7 hours ago
Alia Bhatt turns makeup artist, asks fans, “Kisko tutorial chahiye?”
7 hours ago
Dharmendra bonds with ‘diehard’ fan on holiday